Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: ZHEJIANG

    Main Sales Markets: Central/South America,Eastern Europe,Asia,Middle East,Africa

  • Sample Provided: no

    Sitagliptin is a novel anti-type 2 diabetes drug.
    Its mechanism of action is different from previous oral hypoglycemic agents. It improves the blood sugar level of diabetic patients by increasing the ability of insulin cells to produce insulin in their own islet β cells and increasing insulin secretion when blood sugar is elevated.

     

    MF: C16H15F6N5O

    MW: 407.318418

Send your message to this supplier
  • From:
  • To:
    Hangzhou Bio-Bounce Technology Co., Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service